A detailed history of Emerald Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Emerald Advisors, LLC holds 3,988 shares of MRK stock, worth $395,529. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,988
Previous 4,822 17.3%
Holding current value
$395,529
Previous $596,000 24.16%
% of portfolio
0.07%
Previous 0.09%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$111.15 - $128.97 $92,699 - $107,560
-834 Reduced 17.3%
3,988 $452,000
Q2 2024

Jul 15, 2024

SELL
$123.8 - $132.96 $436,271 - $468,551
-3,524 Reduced 42.22%
4,822 $596,000
Q1 2024

Apr 25, 2024

BUY
$113.24 - $131.95 $11,890 - $13,854
105 Added 1.27%
8,346 $1.1 Million
Q4 2023

Jan 23, 2024

BUY
$100.18 - $109.02 $28,350 - $30,852
283 Added 3.56%
8,241 $898,000
Q3 2023

Oct 13, 2023

BUY
$102.95 - $114.33 $113,553 - $126,105
1,103 Added 16.09%
7,958 $819,000
Q2 2023

Aug 02, 2023

BUY
$108.61 - $118.38 $48,440 - $52,797
446 Added 6.96%
6,855 $790,000
Q1 2023

Apr 07, 2023

SELL
$102.94 - $114.86 $94,293 - $105,211
-916 Reduced 12.51%
6,409 $681,000
Q4 2022

Jan 20, 2023

SELL
$87.44 - $112.11 $108,600 - $139,240
-1,242 Reduced 14.5%
7,325 $0
Q3 2022

Oct 12, 2022

SELL
$84.53 - $94.96 $7,692 - $8,641
-91 Reduced 1.05%
8,567 $738,000
Q2 2022

Aug 01, 2022

SELL
$83.49 - $94.64 $95,429 - $108,173
-1,143 Reduced 11.66%
8,658 $789,000
Q1 2022

Apr 26, 2022

BUY
$73.51 - $82.4 $29,698 - $33,289
404 Added 4.3%
9,801 $804,000
Q4 2021

Jan 19, 2022

BUY
$72.28 - $90.54 $82,905 - $103,849
1,147 Added 13.9%
9,397 $720,000
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $36,413 - $40,045
508 Added 6.56%
8,250 $620,000
Q2 2021

Aug 02, 2021

BUY
$70.31 - $77.77 $53,224 - $58,871
757 Added 10.84%
7,742 $602,000
Q1 2021

Apr 20, 2021

BUY
$68.86 - $81.11 $16,939 - $19,953
246 Added 3.65%
6,985 $538,000
Q4 2020

Feb 05, 2021

BUY
$71.77 - $79.65 $56,052 - $62,206
781 Added 13.11%
6,739 $551,000
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $13,757 - $15,594
188 Added 3.26%
5,958 $494,000
Q2 2020

Aug 10, 2020

BUY
$70.42 - $80.13 $29,224 - $33,253
415 Added 7.75%
5,770 $446,000
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $339,292 - $470,276
5,355 New
5,355 $409,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Emerald Advisors, LLC Portfolio

Follow Emerald Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisors, LLC with notifications on news.